Petros Pharmaceuticals, Inc. (PTPI) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$4.64M | -0.3% |
| 2024 | -$4.63M | +66.0% |
| 2023 | -$13.62M | +31.6% |
| 2022 | -$19.92M | -10.3% |
| 2021 | -$18.05M | -4.4% |
| 2020 | -$17.28M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$4.64M | -0.3% |
| 2024 | -$4.63M | +66.0% |
| 2023 | -$13.62M | +31.6% |
| 2022 | -$19.92M | -10.3% |
| 2021 | -$18.05M | -4.4% |
| 2020 | -$17.28M | — |